Ryoko Sakai    Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine    Position
Article types	Original article
Language	English
Peer review	Peer reviewed
Title	Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.
Journal	Formal name：Modern rheumatology Abbreviation：Mod Rheumatol ISSN code：(1439-7609)1439-7595(Linking)
Domestic / Foregin	Foregin
Volume, Issue, Page	23(6),pp.1085-93
Author and coauthor	Watanabe Kaori, Sakai Ryoko, Koike Ryuji, Sakai Fumikazu, Sugiyama Haruhito, Tanaka Michi, Komano Yukiko, Akiyama Yuji, Mimura Toshihide, Kaneko Motohide, Tokuda Hitoshi, Iso Takenobu, Motegi Mitsuru, Ikeda Kei, Nakajima Hiroshi, Taki Hirofumi, Kubota Tetsuo, Kodama Hirotaka, Sugii Shoji, Kuroiwa Takashi, Nawata Yasushi, Shiozawa Kazuko, Ogata Atsushi, Sawada Shigemasa, Matsukawa Yoshihiro, Okazaki Takahiro, Mukai Masaya, Iwahashi Mitsuhiro, Saito Kazuyoshi, Tanaka Yoshiya, Nanki Toshihiro, Miyasaka Nobuyuki, Harigai Masayoshi
Publication date	2013/11
Summary	PCP may occur early in the course of adalimumab therapy in patients with RA. Careful monitoring, early diagnosis, and proper management are mandatory to secure a good prognosis for these patients.
DOI	10.1007/s10165-012-0796-5
PMID	23212592